One direct-acting anticoagulant stands out as the least likely to cause dangerous bleeding in elderly patients with atrial fibrillation, according to a new study. But other new research questions the ...

Non-vitamin K antagonist oral anticoagulants offer an alternative to warfarin and heparins for treating atrial fibrillation and venous thromboembolism Abstract The disadvantages of warfarin and ...

Anticoagulant drugs are used to reduce the ability of the blood to clot. Examples of anticoagulants include aspirin, heparin and warfarin.Brought to you by NHS Choices Subscribe today for unlimited ...

Background: The benefits and harms of anticoagulants for people near the end of life are not well understood, nor is it known what proportion of patients discontinue these medications. We aimed to ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

It is uncertain whether bridging anticoagulation is necessary for patients with atrial fibrillation who need an interruption in warfarin treatment for an elective operation or other elective invasive ...

Anticoagulant or antiplatelet drugs, sometimes called blood thinners, help prevent blood clots. There are many options, including heparin and warfarin. Preventing clots reduces the risk of stroke and ...

Idarucizumab is the first agent to be licensed in the UK that reverses the anticoagulant effect of a non‑vitamin K antagonist oral anticoagulant (NOAC). Its action is specific against the NOAC ...